352 related articles for article (PubMed ID: 30681366)
1. Activation of Notch signaling by soluble Dll4 decreases vascular permeability via a cAMP/PKA-dependent pathway.
Boardman R; Pang V; Malhi N; Lynch AP; Leach L; Benest AV; Bates DO; Machado MJC
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1065-H1075. PubMed ID: 30681366
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin D2-DP signaling promotes endothelial barrier function via the cAMP/PKA/Tiam1/Rac1 pathway.
Kobayashi K; Tsubosaka Y; Hori M; Narumiya S; Ozaki H; Murata T
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):565-71. PubMed ID: 23307871
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia.
Al Haj Zen A; Oikawa A; Bazan-Peregrino M; Meloni M; Emanueli C; Madeddu P
Circ Res; 2010 Jul; 107(2):283-93. PubMed ID: 20508179
[TBL] [Abstract][Full Text] [Related]
4. RhoA-mediated signaling in Notch-induced senescence-like growth arrest and endothelial barrier dysfunction.
Venkatesh D; Fredette N; Rostama B; Tang Y; Vary CP; Liaw L; Urs S
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):876-82. PubMed ID: 21273559
[TBL] [Abstract][Full Text] [Related]
5. Feed-forward signaling by membrane-bound ligand receptor circuit: the case of NOTCH DELTA-like 4 ligand in endothelial cells.
Caolo V; van den Akker NM; Verbruggen S; Donners MM; Swennen G; Schulten H; Waltenberger J; Post MJ; Molin DG
J Biol Chem; 2010 Dec; 285(52):40681-9. PubMed ID: 20959466
[TBL] [Abstract][Full Text] [Related]
6. Delta like 4 regulates cerebrovascular development and endothelial integrity via DLL4-NOTCH-CLDN5 pathway and is vulnerable to neonatal hyperoxia.
Ke X; Xia S; Yu W; Mabry S; Fu Q; Menden HL; Sampath V; Lane RH
J Physiol; 2024 May; 602(10):2265-2285. PubMed ID: 38632887
[TBL] [Abstract][Full Text] [Related]
7. Delta-like 4 inhibits choroidal neovascularization despite opposing effects on vascular endothelium and macrophages.
Camelo S; Raoul W; Lavalette S; Calippe B; Cristofaro B; Levy O; Houssier M; Sulpice E; Jonet L; Klein C; Devevre E; Thuret G; Duarte A; Eichmann A; Leconte L; Guillonneau X; Sennlaub F
Angiogenesis; 2012 Dec; 15(4):609-22. PubMed ID: 22869002
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandins PGE(2) and PGI(2) promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation.
Birukova AA; Zagranichnaya T; Fu P; Alekseeva E; Chen W; Jacobson JR; Birukov KG
Exp Cell Res; 2007 Jul; 313(11):2504-20. PubMed ID: 17493609
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietin-1/Tie2 signal augments basal Notch signal controlling vascular quiescence by inducing delta-like 4 expression through AKT-mediated activation of beta-catenin.
Zhang J; Fukuhara S; Sako K; Takenouchi T; Kitani H; Kume T; Koh GY; Mochizuki N
J Biol Chem; 2011 Mar; 286(10):8055-8066. PubMed ID: 21212269
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function.
Williams CK; Li JL; Murga M; Harris AL; Tosato G
Blood; 2006 Feb; 107(3):931-9. PubMed ID: 16219802
[TBL] [Abstract][Full Text] [Related]
11. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis.
Djokovic D; Trindade A; Gigante J; Badenes M; Silva L; Liu R; Li X; Gong M; Krasnoperov V; Gill PS; Duarte A
BMC Cancer; 2010 Nov; 10():641. PubMed ID: 21092311
[TBL] [Abstract][Full Text] [Related]
12. Synaptojanin-2 binding protein stabilizes the Notch ligands DLL1 and DLL4 and inhibits sprouting angiogenesis.
Adam MG; Berger C; Feldner A; Yang WJ; Wüstehube-Lausch J; Herberich SE; Pinder M; Gesierich S; Hammes HP; Augustin HG; Fischer A
Circ Res; 2013 Nov; 113(11):1206-18. PubMed ID: 24025447
[TBL] [Abstract][Full Text] [Related]
13. Intermedin induces loss of coronary microvascular endothelial barrier via derangement of actin cytoskeleton: role of RhoA and Rac1.
Aslam M; Gündüz D; Schuler D; Li L; Sharifpanah F; Sedding D; Piper HM; Noll T
Cardiovasc Res; 2011 Nov; 92(2):276-86. PubMed ID: 21816966
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of VEGF-A-induced increase in vascular permeability by an integrin α3β1-Shp-1-cAMP/PKA pathway.
Kim SH; Cho YR; Kim HJ; Oh JS; Ahn EK; Ko HJ; Hwang BJ; Lee SJ; Cho Y; Kim YK; Stetler-Stevenson WG; Seo DW
Blood; 2012 Dec; 120(24):4892-902. PubMed ID: 23074279
[TBL] [Abstract][Full Text] [Related]
15. Nrf2 acts cell-autonomously in endothelium to regulate tip cell formation and vascular branching.
Wei Y; Gong J; Thimmulappa RK; Kosmider B; Biswal S; Duh EJ
Proc Natl Acad Sci U S A; 2013 Oct; 110(41):E3910-8. PubMed ID: 24062466
[TBL] [Abstract][Full Text] [Related]
16. PKA compartmentalization via AKAP220 and AKAP12 contributes to endothelial barrier regulation.
Radeva MY; Kugelmann D; Spindler V; Waschke J
PLoS One; 2014; 9(9):e106733. PubMed ID: 25188285
[TBL] [Abstract][Full Text] [Related]
17. PEDF regulates vascular permeability by a γ-secretase-mediated pathway.
Cai J; Wu L; Qi X; Li Calzi S; Caballero S; Shaw L; Ruan Q; Grant MB; Boulton ME
PLoS One; 2011; 6(6):e21164. PubMed ID: 21695048
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rb1 ameliorates lipopolysaccharide-induced albumin leakage from rat mesenteric venules by intervening in both trans- and paracellular pathway.
Zhang Y; Sun K; Liu YY; Zhang YP; Hu BH; Chang X; Yan L; Pan CS; Li Q; Fan JY; He K; Mao XW; Tu L; Wang CS; Han JY
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G289-300. PubMed ID: 24356882
[TBL] [Abstract][Full Text] [Related]
19. Exendin-4 promotes endothelial barrier enhancement via PKA- and Epac1-dependent Rac1 activation.
Li AQ; Zhao L; Zhou TF; Zhang MQ; Qin XM
Am J Physiol Cell Physiol; 2015 Jan; 308(2):C164-75. PubMed ID: 25377089
[TBL] [Abstract][Full Text] [Related]
20. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
